- Global Pharma News & Resources

Global 3D Cell Culture Market is expected to grow at a CAGR of 22.2% during the forecast period 2019-2026

A new research report published by Fior Markets with the title 3D Cell Culture Market by Product (Scaffold-Based 3d Cell Culture, Scaffold-Free 3d Cell Culture, Others), End-User, Application Region Global Industry Analysis, Market End User, Share, Growth, Trends, and Forecast 2019 to 2026.

As per the report published by Fior Markets, the global 3D cell culture market is expected to grow from USD 631.54 Million in 2018 to USD 3,143.21 Million by 2026 at a CAGR of 22.2% during the forecast period 2019-2026. North America is dominating the market owing to the recent increase in investments for research and development and the healthcare sector. Along with the investments, the positive support of the government has led to the escalation of the market of 3D cell culture.


Leading companies in the 3D cell culture industry include 3D Biotek, LLC, Advanced Biomatrix, Inc., Becton, Dickinson and Company, Corning Incorporated, Kuraray Co., Ltd., Lonza Group Ltd., Merck & Co., Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., VWR Corporation, Global Cell Solutions, Inc., InSphero AG, Nanofiber Solutions, Tecan Trading AG, and among others. The 3D Biotek, LLC, Advanced Biomatrix, Inc., Becton, Dickinson and Company, and Corning Incorporated are the top leading companies for the global 3D cell culture market. In order to their enhance market position, the key players are now focusing on adopting the strategies such as product innovations, mergers & acquisitions, recent developments, joint venture, collaborations, and partnership. For instance, in 2014, Corning, Inc. extended its collaboration with ATCC for cell culture research. Through this move, the company will co-develop new applications for existing Corning and ATCC cellular biology products

The 3D cell culture market is segmented on the basis of product, application and end user. The product segment is classified as scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation & 3D bioprinting. The scaffold-based 3D cell culture segment is dominating the market with the highest share of 47.20% in 2018. The high growth in this segment is attributed to the ability of scaffold-based products to mimic in vivo conditions as well as enable the recapitulation of the extracellular environment of cells is driving their adoption among end users. The end user segment is divided into segments such as pharmaceutical & biotechnology companies and research institutes. The pharmaceutical & biotechnology companies segment is dominating the market and valued around USD 378.29 Million. The rising presence of a large number of pharmaceutical and biotechnology companies, rising R&D expenditure, and rising focus on alternative testing models instead of animal techniques are the key drivers for this end-user segment. The growing body of evidence showing the better correlation of 3D cell culture systems to in vivo results has increased the adoption of the 3D cell culture among the pharmaceutical & biotechnology companies. Hence, it has increased pharmaceutical & biotechnology companies’ segment growth. The application segment includes cancer and stem cell research, drug discovery and toxicology testing and tissue engineering and regenerative medicine. Cancer and stem cell research segment is dominating the market with the highest share of 50.90% in 2018 owing to the rising incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations.

The 3D cell culture models are being used in a number of applications, including oncology drug screening, early assessment of compound and drug safety testing, and tissue engineering. 3D cell culture is defined as an in vitro technique where cells are grown in an artificially created environment, which is quite similar to in vivo environment. 3D cell culture help researchers more easily and efficiently perform cell culture. Rising instances of cancer is one of the driving force. Also, rise in demand for organ transplantation and heavy investments in R&D activities are another two factors fuelling the growth of the global 3D cell culture market. But, budget constraint for research-related activities is restricting the growth of the 3D cell culture market. However, evolution of microfluidics-Based 3D cell culture is expected to provide numerous growth opportunities in the forthcoming years.


Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Contact Us
Mark Stone
Phone: +1-201-465-4211

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 13-Jul-2020